MedTrace Logo

Investigating the Effects of Glucodia™ on Glucose Parameters, Triglycerides and Body Weight

NCT02322294 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-06-09

No results posted yet for this study

Summary

This study is investigating the effects of 8 weeks of supplementation with Glucodia™, on glucose parameters, triglycerides and body weight as compared to a placebo. Half of the subjects will be administered Glucodia™, while the other half will receive placebo.

Conditions

  • Glucose Parameters
  • Triglycerides
  • Body Weight

Interventions

DIETARY_SUPPLEMENT

Glucodia™

OTHER

Placebo

Sponsors & Collaborators

  • Fuji Oil Co. Ltd.

    collaborator UNKNOWN

  • KGK Science Inc.

    lead INDUSTRY

Principal Investigators

  • Tetyana Pelipyagina, MD · KGK Science Inc.

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02322294 on ClinicalTrials.gov